Literature DB >> 19789341

Immutable functional attributes of histologic grade revealed by context-independent gene expression in primary breast cancer cells.

Shanaz H Dairkee1, Aejaz Sayeed, Gloria Luciani, Stacey Champion, Zhenhang Meng, Lakshmi R Jakkula, Heidi S Feiler, Joe W Gray, Dan H Moore.   

Abstract

Inherent cancer phenotypes that are independent of fluctuating cross-talk with the surrounding tissue matrix are highly desirable candidates for targeting tumor cells. Our novel study design uses epithelial cell lines derived from low versus high histologic grade primary breast cancer to effectively diminish the breadth of transient variability generated within the tumor microenvironment of the host, revealing a "paracrine-independent expression of grade-associated" (PEGA) gene signature. PEGA members extended beyond "proliferation-driven" signatures commonly associated with aggressive, high-grade breast cancer. The calcium-binding protein S100P was prominent among PEGA genes overexpressed in high-grade tumors. A three-member fingerprint of S100P-correlated genes, consisting of GPRC5A, FXYD3, and PYCARD, conferred poor outcome in multiple breast cancer data sets, irrespective of estrogen receptor status but dependent on tumor size (P < 0.01). S100P silencing markedly diminished coregulated gene transcripts and reversed aggressive tumor behavior. Exposure to pathway-implicated agents, including the calmodulin inhibitor N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, phenothiazine, and chlorpromazine, resulted in rapid apoptotic cell death in high-grade tumor cells resistant to the chemotherapeutic drug cisplatin. This is the first comprehensive study describing molecular phenotypes intimately associated with histologic grade whose expression remains relatively fixed despite an unavoidably changing environment to which tumor cells are invariably exposed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789341      PMCID: PMC2757757          DOI: 10.1158/0008-5472.CAN-09-1564

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo.

Authors:  I D Guerreiro Da Silva; Y F Hu; I H Russo; X Ao; A M Salicioni; X Yang; J Russo
Journal:  Int J Oncol       Date:  2000-02       Impact factor: 5.650

3.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

4.  A human cell line from a pleural effusion derived from a breast carcinoma.

Authors:  H D Soule; J Vazguez; A Long; S Albert; M Brennan
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

5.  What do we mean by validating a prognostic model?

Authors:  D G Altman; P Royston
Journal:  Stat Med       Date:  2000-02-29       Impact factor: 2.373

Review 6.  Identifying and validating causal genetic alterations in human breast cancer.

Authors:  Stephen P Ethier
Journal:  Breast Cancer Res Treat       Date:  2003-04       Impact factor: 4.872

Review 7.  Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation.

Authors:  D D Bikle; Y Oda; Z Xie
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

8.  Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence.

Authors:  Priyamvada Rai; Tamer T Onder; Jennifer J Young; Jose L McFaline; Bo Pang; Peter C Dedon; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-31       Impact factor: 11.205

9.  Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.

Authors:  Howard Y Chang; Julie B Sneddon; Ash A Alizadeh; Ruchira Sood; Rob B West; Kelli Montgomery; Jen-Tsan Chi; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  PLoS Biol       Date:  2004-01-13       Impact factor: 8.029

10.  A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue.

Authors:  Shanaz H Dairkee; Youngran Ji; Yong Ben; Dan H Moore; Zhenhang Meng; Stefanie S Jeffrey
Journal:  BMC Genomics       Date:  2004-07-19       Impact factor: 3.969

View more
  12 in total

Review 1.  S100P: a novel therapeutic target for cancer.

Authors:  Thiruvengadam Arumugam; Craig D Logsdon
Journal:  Amino Acids       Date:  2010-05-28       Impact factor: 3.520

2.  GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.

Authors:  Honggen Liu; Yunchao Zhang; Xuwen Hao; Fanming Kong; Xiaojiang Li; Jianchun Yu; Yingjie Jia
Journal:  Tumour Biol       Date:  2015-07-31

3.  Tissue biomarkers of breast cancer and their association with conventional pathologic features.

Authors:  L Chung; S Shibli; K Moore; E E Elder; F M Boyle; D J Marsh; R C Baxter
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

4.  Negative regulation of UCP2 by TGFβ signaling characterizes low and intermediate-grade primary breast cancer.

Authors:  A Sayeed; Z Meng; G Luciani; L-C Chen; J L Bennington; S H Dairkee
Journal:  Cell Death Dis       Date:  2010-07-15       Impact factor: 8.469

5.  Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells.

Authors:  Maria Gloria Luciani; Junhee Seok; Aejaz Sayeed; Stacey Champion; William H Goodson; Stefanie S Jeffrey; Wenzhong Xiao; Michael Mindrinos; Ronald W Davis; Shanaz H Dairkee
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

Review 6.  The emerging roles of GPRC5A in diseases.

Authors:  Honglei Zhou; Isidore Rigoutsos
Journal:  Oncoscience       Date:  2014-11-25

7.  GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.

Authors:  H Zhou; A G Telonis; Y Jing; N L Xia; L Biederman; M Jimbo; F Blanco; E Londin; J R Brody; I Rigoutsos
Journal:  Cell Death Dis       Date:  2016-07-14       Impact factor: 8.469

8.  Orphan G protein-coupled receptor GPRC5A modulates integrin β1-mediated epithelial cell adhesion.

Authors:  Daria R Bulanova; Yevhen A Akimov; Anne Rokka; Teemu D Laajala; Tero Aittokallio; Petri Kouvonen; Teijo Pellinen; Sergey G Kuznetsov
Journal:  Cell Adh Migr       Date:  2017-02-06       Impact factor: 3.405

9.  Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.

Authors:  Aejaz Sayeed; Gloria Luciani-Torres; Zhenhang Meng; James L Bennington; Dan H Moore; Shanaz H Dairkee
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines.

Authors:  Ashley A Powell; Amirali H Talasaz; Haiyu Zhang; Marc A Coram; Anupama Reddy; Glenn Deng; Melinda L Telli; Ranjana H Advani; Robert W Carlson; Joseph A Mollick; Shruti Sheth; Allison W Kurian; James M Ford; Frank E Stockdale; Stephen R Quake; R Fabian Pease; Michael N Mindrinos; Gyan Bhanot; Shanaz H Dairkee; Ronald W Davis; Stefanie S Jeffrey
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.